Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Compass Therapeutics (CMPX) Return on Capital Employed (2023 - 2025)

Compass Therapeutics (CMPX) has disclosed Return on Capital Employed for 3 consecutive years, with 0.34% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 7.0% to 0.34% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.34% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.44% for FY2025, 3.0% down from the prior year.
  • Return on Capital Employed hit 0.34% in Q4 2025 for Compass Therapeutics, up from 0.44% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.32% in Q4 2023 to a low of 0.62% in Q2 2025.
  • Historically, Return on Capital Employed has averaged 0.42% across 3 years, with a median of 0.37% in 2024.
  • Biggest YoY gain for Return on Capital Employed was 7bps in 2025; the steepest drop was -25bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.32% in 2023, then fell by -29bps to 0.42% in 2024, then increased by 17bps to 0.34% in 2025.
  • Business Quant data shows Return on Capital Employed for CMPX at 0.34% in Q4 2025, 0.44% in Q3 2025, and 0.62% in Q2 2025.